RL95-2 Cells
































General information
Description | The cells possess alpha keratin, well defined junctional complexes, tonofilaments and surface microvilli. |
---|---|
Organism | Human |
Tissue | Uterus, endometrium |
Disease | Endometrial adenosquamous carcinoma |
Synonyms | RL95_2, RL-95-2, RL-952, RL952, RL95 |
Characteristics
Age | 65 years |
---|---|
Gender | Female |
Ethnicity | European |
Morphology | Epithelial |
Growth properties | Adherent |
Identifiers / Biosafety / Citation
Citation | RL95-2 (Cytion catalog number 305062) |
---|---|
Biosafety level | 1 |
Expression / Mutation
Handling
Culture Medium | DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a) |
---|---|
Medium supplements | Supplement the medium with 10% FBS, 0.005 mg/mL insulin |
Passaging solution | Accutase |
Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
Split ratio | 1:2 to 1:4 |
Fluid renewal | 2 to 3 times per week |
Freeze medium | As a cryopreservation medium, use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
Handling of cryopreserved cultures |
|
Quality control / Genetic profile / HLA
Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
---|---|
STR profile |
Amelogenin: x,x
CSF1PO: 10,11
D13S317: 8,12
D16S539: 11,13
D5S818: 10,11
D7S820: 10
TH01: 9,9.3
TPOX: 8
vWA: 16,2
D3S1358: 14,16
D21S11: 28,29
D18S51: 10,14
Penta E: 5,11
Penta D: 9
D8S1179: 10,14
FGA: 20,22
D6S1043: 19
D2S1338: 22,23
D12S391: 15,21
D19S433: 15
|
Certificate of Analysis (CoA)
Lot Number | Certificate Type | Date | Catalog Number |
---|---|---|---|
305062-131123 | Certificate of Analysis | 23. May. 2025 | 305062 |